Immunotherapeutic Challenges for Pediatric Cancers
Year: 2019
Type: article
Abstract: Solid tumors contain a mixture of malignant cells and non-malignant infiltrating cells that often create a chronic inflammatory and immunosuppressive microenvironment that restricts immunotherapeutic approaches. Although childhood and adult cancers share some similarities related to microenvironmental changes, pediatric cancers are unique, and adult cancer practices may not be wholly applicable to our pediatric patients. This review highlights the differences in tumorigenesis, viral infection, and immunologic response between children and adults that need to be considered when trying to apply experiences from experimental therapies in adult cancer patients to pediatric cancers.
Source: Molecular Therapy — Oncolytics
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,500
Awards: G1442899210, Tumor-mediated metabolic modulation of regulatory T cells, G180321955, G3164291660, G3522905636, G4297338006, G5225000690, Oncogenic fusion gene FAX-FKHR in driving metabolic reprogramming in alveolar rhabdomyosarcoma, Metabolic reprogramming of tumor microenvironment to maximize immunotherapy for pediatric cancers, Pediatric Ohio-New York Cancer (Peds-ONC) Immunotherapy Center, G8291647282, Dissect and target Arginine-polyamine metabolic axis in T cell mediated inflammation and autoimmunity
OpenAlex ID: W2970664994
